Insider Transactions in Q1 2024 at Tenaya Therapeutics, Inc. (TNYA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Timothy Hoey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,300
-1.33%
|
$23,100
$7.0 P/Share
|
|
Feb 23
2024
|
Leone D Patterson Chief Fin. and Bus. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+26.77%
|
-
|
|
Feb 23
2024
|
Whittemore Tingley Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+24.38%
|
-
|
|
Feb 23
2024
|
Timothy Hoey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+4.79%
|
-
|
|
Feb 23
2024
|
Faraz Ali Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+30.03%
|
-
|
|
Feb 20
2024
|
Timothy Hoey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,569
-1.35%
|
$32,845
$5.74 P/Share
|
|
Feb 16
2024
|
Whittemore Tingley Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,500
-8.12%
|
$32,500
$5.86 P/Share
|
|
Feb 16
2024
|
Timothy Hoey Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,681
-1.89%
|
$23,405
$5.86 P/Share
|
|
Feb 16
2024
|
Faraz Ali Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,358
-5.32%
|
$31,790
$5.86 P/Share
|
|
Feb 16
2024
|
Leone D Patterson Chief Fin. and Bus. Officer |
SELL
Open market or private sale
|
Direct |
5,201
-7.89%
|
$26,005
$5.86 P/Share
|
|
Feb 12
2024
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
2,222,222
+14.05%
|
$8,888,888
$4.5 P/Share
|
|
Feb 12
2024
|
David V Goeddel |
BUY
Open market or private purchase
|
Indirect |
2,222,222
+14.05%
|
$8,888,888
$4.5 P/Share
|